Obermatt
See Similar Stocks →

AxoGen

NAQ:AXGN · US05463X1063
Health Care Equipment & SuppliesSmall

360

43
Profit price95
Owner Earnings Yield1
Dividend Yield1
Price/Sales19
EV / Gross Profit11
Price/Book13
Return on Capital27
Cash Return on Capital32
Return on Equity29
EBIT Margin23
Gross Profitability88
Accruals81
Owner Earnings Margin28
Sales growth80
Profit Growth48
Long-Term EPS Growth4
Owner Earnings Growth1
Reinvestment95
Price momentum100
Debt load85
Refinancing36
Debt Payback1
Liquidity34
Analyst ratings80
Opinion Changes50
Price Target Upside34
Market mood21
Value Creation4/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

AxoGen doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
TypePublic Company
ExchangeNASDAQCM
Employees520
Websiteaxogeninc.com
ISINUS05463X1063
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)D.J. US Medical Equipment
Themes
Pain ManagementAssistive TechnologyBiomedical EngineeringNeuroscienceSurgeryCentral Nervous SystemOrthopaedicsNeurology

Description

Axogen, Inc. (‘Axogen’) focuses specifically on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company is passionate about providing the opportunity to restore nerve function and qua…

Analysis

Middle-of-the-road

Axogen, Inc. sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

Valuation data is not available for this company.

Growth is moderate; the safety picture is adequate. The company scores 4/20 on our value-creation score: not creating value.

Flags to be aware of: Some accounting patterns deserve a closer look. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
51
2023202420252026

All-time high

67

Jan 2023

All-time low

34

Jan 2024

Average rank

52

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
19
41
75
79
Price/Earnings
3
13
26
26
Price/Book
13
25
59
66
Dividend Yield
1
1
1
1
Value (overall)
1
31
64
63

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare AxoGen with its peers
CONMED
NYQ:CNMD
44
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
SANUWAVE Health
NMQ:SNWV
33
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
AtriCure
NMQ:ATRC
75
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
Integra LifeSciences
NSQ:IART
21
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
Spectral AI
NAQ:MDAI
44
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
LeMaitre Vascular
NMQ:LMAT
78
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →